Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Panitumumab-IRDye800 Imaging for Pancreatic Cancer
Recruiting1 awardPhase 1 & 2
Palo Alto, California
This trial is testing a new way to find pancreatic cancer during surgery, by using a combination of the drug panitumumab and an investigational dye called IRDye800CW. The dye makes cancer cells more visible when seen through a special camera.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service